Giovanni Barosi
0000-0002-8357-7192
9 papers found
Refreshing results…
Primary myelofibrosis: rs2010963 VEGFA polymorphism favors a prefibrotic phenotype and is associated with higher risk of thrombosis
New Markers of Disease Progression in Myelofibrosis
Clinical Relevance of VEGFA (rs3025039) +936 C>T Polymorphism in Primary Myelofibrosis: Susceptibility, Clinical Co-Variates, and Outcomes
Impact of the rs1024611 Polymorphism of CCL2 on the Pathophysiology and Outcome of Primary Myelofibrosis
Gene expression profile correlates with molecular and clinical features in patients with myelofibrosis
Reduced CXCR4-expression on CD34-positive blood cells predicts outcomes of persons with primary myelofibrosis
Plasma sIL-2Rα levels are associated with disease progression in myelofibrosis with JAK2V617F but not CALR mutation
Management of infectious complications in multiple myeloma patients: Expert panel consensus-based recommendations
Brentuximab Vedotin in CD30-Positive Lymphomas: A SIE, SIES, and GITMO Position Paper
Missing publications? Search for publications with a matching author name.